- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05137821
Efficacy of Er: YSGG Laser in Treatment of Peri-implantitis
Efficacy of Er: YSGG Laser on Oral Biofilm Removal From Implant Surface and Its Biological Response to Periodontal Tissues in Treatment of Peri-implantitis (An Ex Vivo Study)
This study will be carried out to evaluate the efficacy of Er: YSGG laser on oral biofilm removal from implant surface in various peri-implant defect morphology in the treatment of peri-implantitis as a primary objective.
To assess the morphological changes and the biological response (biocompatibility) of implant surface after Er: YSGG laser therapy through Profilometer analysis and cell culture process to detect attachment, differentiation, and mineralization of Isolated rat Bone Marrow Mesenchymal stem cells (rBMMSCs) respectively as secondary objectives.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will be carried out to evaluate the efficacy of Er: YSGG laser on oral biofilm removal from implant surface in various peri-implant defect morphology in the treatment of peri-implantitis as a primary objective.
To assess the morphological changes and the biological response (biocompatibility) of implant surface after Er: YSGG laser therapy through Profilometer analysis and cell culture process to detect attachment, differentiation, and mineralization of Isolated rat Bone Marrow Mesenchymal stem cells (rBMMSCs) respectively as secondary objectives.
The study was designed as an Ex Vivo study. Four periodontally and systemically healthy volunteers of both gender are included in this study for the formation of in vivo plaque biofilm. Each volunteer will wear a hard resin splint carrying six rough (machined implant; 3.3mm diameter, 8mm length) for 4 days to accumulate dental plaque naturally on the titanium surfaces of the implants.
Therefore, 24 implants will be assessed for Er: YSGG laser therapy in different bone defect simulators.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 11411
- Ain Shams Dental School
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Sex: female or male.
- Age: 25 - 55 years.
- Medically controlled according to medical coding of review of systems (ROS)
Exclusion Criteria:
Tobacco smoking for at least 6 months before the study enrollment
- Participants with ill-fitting restorations in both upper first molars that affect the stability of the stent.
- Participants not following oral hygiene instructions.
- Participants on dental treatment during the study period.
- Participants with a history of drug administration
- Vulnerable group.
- Participants with long-term mouthwash administration.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: non tested comparative group
two sealed new implants as a control
|
new sealed implant without any surface treatment
|
Experimental: Er: YSGG laser tested group
24 infected implants divided into four subgroups that will be decontaminated by Er: YSGG laser in various peri-implant defects
|
Er: YSGG laser decontamination of infected implant surfaces to simulate peri-implantitis therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
visual inspection of the oral biofilm removal efficacy by image analysis software (Adobe Photoshop
Time Frame: 2 weeks
|
evaluate the efficacy of Er: YSGG laser on oral biofilm removal from implant surface in various peri-implant defect morphology |
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Profilometer analysis of surface roughness changes
Time Frame: 1 month
|
assess the morphological changes of implant surface after Er: YSGG laser therapy through Profilometer analysis
|
1 month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
biocompatibility test of the surface
Time Frame: 2 months
|
assess the biological response (biocompatibility) of implant surface after Er: YSGG laser therapy through cell culture process to detect attachment, differentiation, and mineralization of Isolated rat Bone Marrow Mesenchymal stem cells (rBMMSCs)
|
2 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FDASU-REC ID210314
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peri-Implantitis
-
PolyPid Ltd.MIS Implant Technologies, LtdCompleted
-
University of ManitobaUnknownPeri ImplantitisCanada
-
University of ValenciaCompletedEarly Apical Peri-implantitis
-
Rambam Health Care CampusRecruitingDental Implants,Peri-implantitis,SmokingIsrael
-
Tuğba ŞAHİNCompletedPeri-Implantitis, Peri-implant MucositisTurkey
-
Proed, Torino, ItalyCompleted
-
University of ZagrebNot yet recruitingPeri-implant Mucositis | Peri-Implantitis and Peri-implant Mucositis | Peri-implant Health | Periimplant Diseases | Periimplant Bone Loss
-
Center of Implantology, Oral and Maxillofacial...Recruiting
-
Center of Implantology, Oral and Maxillofacial...Recruiting
-
University of BaghdadRecruiting
Clinical Trials on no therapy
-
Ottawa Hospital Research InstituteRecruiting
-
Bayside HealthMonash University; Baker Heart and Diabetes Institute; Ambulance Victoria; FALCK...UnknownCoronary Artery Disease | Acute Myocardial InfarctionAustralia
-
Case Comprehensive Cancer CenterCompletedMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin LymphomaUnited States
-
University of MinnesotaRecruitingInjection Site Irritation | Anesthesia; HypothermiaUnited States
-
University of NebraskaNot yet recruitingPeripheral Arterial Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Peripheral Artery Occlusive DiseaseUnited States
-
NHS Greater Glasgow and ClydeUniversity of GlasgowCompletedSpinal Cord InjuryUnited Kingdom
-
Parc de Salut MarCompletedObstructive Chronic Bronchitis With Acute ExacerbationSpain
-
DermTechRecruitingAtopic DermatitisUnited States
-
ResMedCompletedBreathing, MouthAustralia
-
Luz A. Venta, MDCompletedBreast Cancer | Triple Negative Breast Cancer | Emotions | ImmunologyUnited States